ICON completes acquisition of MediMedia Pharma

The acquisition extends ICON’s leadership in commercialisation and market access services


The acquisition brings new scientific communications capabilities

ICON has completed the acquisition of MediMedia Pharma Solutions. The acquisition brings ICON new scientific communications capabilities which together with ICON's existing Commercialisation and Outcomes practices, creates the industry's leading integrated market access solution.

Commenting on the completion of the acquisition, Mr Ciaran Murray, CEO, ICON "Helping customers establish and communicate the value of their products has become increasingly important as payers look for evidence linking efficacy, value and price. MediMedia deepens the expertise and capabilities of our market-leading commercialisation and outcomes group and brings outstanding scientific and medical communications capabilities. We are delighted to welcome them to the ICON team."


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email